Adjuvant cytotoxic chemotherapy for early breast cancer: doubts and decisions
- 1 May 1998
- journal article
- viewpoint
- Published by Elsevier in The Lancet
- Vol. 351 (9114) , 1506-1507
- https://doi.org/10.1016/s0140-6736(97)11247-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1997
- Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancerThe Lancet, 1996
- Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalThe Lancet, 1996
- Offering Choice of treatment to patients with cancers. A review based on a symposium held at the 10th annual conference of the British psychosocial oncology group, December 1993European Journal Of Cancer, 1995
- Does it matter where you live? Treatment variation for breast cancer in YorkshireBritish Journal of Cancer, 1995
- Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study.Journal of Clinical Oncology, 1990
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- Cancer patients' perceptions of their disease and its treatmentBritish Journal of Cancer, 1988